Le Lézard
Classified in: Health
Subject: RCL

Ventura Foods Issues Allergy Alert on Undeclared Fish (Anchovy) Allergen in Publix Deli Carolina-Style Mustard BBQ Sauce


BREA, Calif. , Jan. 8, 2024 /PRNewswire-PRWeb/ -- Ventura Foods of Brea, Calif. has initiated a voluntary recall on Publix Deli Carolina-Style Mustard BBQ Sauce sold exclusively at Publix Super Markets, Inc., because it contains Traditional Sweet & Spicy BBQ Sauce that may contain a fish (anchovy) allergen that is not declared on the label. People who have an allergy or severe sensitivity to fish (anchovy) run the risk of serious or life-threatening allergic reaction if they consume these products. 

This recall only impacts Publix Deli Carolina-Style Mustard BBQ Sauce with the use by date of April 08, 2024. This product was sold at Publix stores in Alabama, Florida, Georgia, North Carolina, South Carolina, Tennessee and Virginia.

The product details are as follows:

Product Name

Package Size

UPC Code

Use By Date

Carolina-Style Mustard BBQ Sauce

2oz package ? individually sold

0 41415 57162 4

APR 08 24B

To date, there have been no reported cases of illness.

If consumers have a product affected by this recall, they are advised to discard it immediately or return the product to their local store for a full refund. Consumers who have additional questions should call Ventura Foods Customer Relations at (888) 500-0086 Monday through Friday, 8:30am-4:30pm CT.

Publix Super Markets have removed all affected products from its shelves. No other Ventura Foods products are affected by this recall.

SOURCE Ventura Foods


These press releases may also interest you

at 03:20
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...

at 03:00
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...

at 02:30
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA...

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...

3 jui 2024
YOUR LEGAL RIGHTS MAY BE AFFECTED There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...



News published on and distributed by: